Ornithine phenylacetate: Phase IIa data

Top-line data from 38 patients in an investigator-sponsored, double-blind, Spanish Phase IIa trial showed that 10 g daily IV

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE